KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to -$2.0 million.

  • Edwards Lifesciences' Net Income towards Common Stockholders fell 10007.39% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.7 million, marking a year-over-year decrease of 9907.25%. This contributed to the annual value of $2.8 billion for FY2024, which is 144609.81% up from last year.
  • Edwards Lifesciences' Net Income towards Common Stockholders amounted to -$2.0 million in Q3 2025, which was down 10007.39% from -$4.4 million recorded in Q2 2025.
  • In the past 5 years, Edwards Lifesciences' Net Income towards Common Stockholders registered a high of $2.7 billion during Q3 2024, and its lowest value of -$7.2 million during Q1 2025.
  • Its 5-year average for Net Income towards Common Stockholders is $329.7 million, with a median of $335.3 million in 2021.
  • Per our database at Business Quant, Edwards Lifesciences' Net Income towards Common Stockholders surged by 544774.59% in 2024 and then plummeted by 54000.0% in 2025.
  • Edwards Lifesciences' Net Income towards Common Stockholders (Quarter) stood at $335.3 million in 2021, then grew by 18.82% to $398.4 million in 2022, then tumbled by 90.81% to $36.6 million in 2023, then rose by 7.38% to $39.3 million in 2024, then plummeted by 105.09% to -$2.0 million in 2025.
  • Its last three reported values are -$2.0 million in Q3 2025, -$4.4 million for Q2 2025, and -$7.2 million during Q1 2025.